Korea S.E.
23:00:00 27/05/2024 BST
5-day change
1st Jan Change
2,515
KRW
-0.59%
-6.33%
-36.97%
MEKICS CO., Ltd announced that it has received KRW 2.267949711 billion in funding from Sos Oxygene Participations SAS
On October 23, 2020, MEKICS CO., Ltd (KOSDAQ:A058110) closed the transaction. The company amended the terms of the transaction. The company now issued 1,357,241 common shares at a price of KRW 1,671 per shares for gross proceeds of KRW 2,267,949,711 in the transaction.
Tranche Update on MEKICS CO., Ltd's Equity Buyback Plan announced on October 30, 2023.
01-24
CI
Tranche Update on MEKICS CO., Ltd's Equity Buyback Plan announced on October 30, 2023.
01-24
CI
MEKICS CO., Ltd's Equity Buyback announced on October 30, 2023, has closed with 182,000 shares, representing 1.16% for KRW 685.22 million.
01-22
CI
MEKICS CO., Ltd announces an Equity Buyback for 182,000 shares.
30/10/23
CI
MEKICS CO., Ltd authorizes a Buyback Plan.
29/10/23
CI
MEKICS CO., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
17/03/23
CI
MEKICS CO., Ltd(KOSDAQ:A058110) dropped from S&P Global BMI Index
19/09/22
CI
MEKICS CO., Ltd's Equity Buyback announced on October 5, 2021, has expired with.
04/01/22
CI
MEKICS CO., Ltd announces an Equity Buyback for 200,000 shares.
05/10/21
CI
MEKICS CO., Ltd authorizes a Buyback Plan.
04/10/21
CI
Tranche Update on MEKICS CO., Ltd's Equity Buyback Plan announced on August 31, 2021.
01/10/21
CI
Tranche Update on MEKICS CO., Ltd's Equity Buyback Plan announced on August 31, 2021.
01/10/21
CI
MEKICS CO., Ltd's Equity Buyback announced on August 31, 2021, has closed with 91,000 shares, representing 0.57% for KRW 1,013.06 million.
30/09/21
CI
MEKICS CO., Ltd(KOSDAQ:A058110) added to S&P Global BMI Index
20/09/21
CI
MEKICS CO., Ltd announces an Equity Buyback for 91,000 shares.
31/08/21
CI
MEKICS CO., Ltd authorizes a Buyback Plan.
30/08/21
CI
Tranche Update on MEKICS CO., Ltd's Equity Buyback Plan announced on May 26, 2021.
04/06/21
CI
MEKICS CO., Ltd's Equity Buyback announced on May 26, 2021, has closed with 80,000 shares, representing 0.5% for KRW 1,253.43 million.
03/06/21
CI
MEKICS CO., Ltd announces an Equity Buyback for 80,000 shares.
26/05/21
CI
MEKICS CO., Ltd authorizes a Buyback Plan.
25/05/21
CI
MEKICS CO., Ltd cancelled the acquisition of remaining 33.5% stake in MEK Healthcare Co., Ltd.
11/02/21
CI
MEKICS CO., Ltd announced that it has received KRW 2.267949711 billion in funding from Sos Oxygene Participations SAS
22/10/20
CI
MEKICS CO., Ltd announced that it expects to receive KRW 2.353455894 billion in funding from Sos Oxygene Participations SAS
04/08/20
CI
MEKICS CO., Ltd announced that it has received KRW 3.651 billion in funding
23/04/20
CI
MEKICS CO., Ltd agreed to acquire remaining 33.5% stake in MEK Healthcare Co., Ltd. for approximately ¥ 420 million.
19/04/20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
MEKICS CO., Ltd is a Korea-based company principally engaged in manufacturing medical equipment. The Companyâs products mainly consist of artificial respirators used for critical patient and newborns, portable artificial respirators used for emergency, high oxygen artificial respirators , continuous positive pressure respirators ,patient monitors used for monitoring patient vital sign , measuring appliance used for measuring oxygen saturation.
More about the company
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
MEKICS CO., LTD 
